A First-in-Human Study of QY211 Gel in Adult Subjects
Clinical trial NCT05843422 · UNKNOWN
Trial details
- NCT number
- NCT05843422
- Sponsor
- E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2024-10-23
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.